P. Andrew Futreal

What is he best known for?

The fields of study he is best known for:

• Gene
• Mutation
• Cancer

His primary areas of study are Genetics, Human genome, Cancer research, Genome and Mutation. His Human genome research is multidisciplinary, incorporating elements of DNA sequencing and Paired-end tag. His Cancer research research is multidisciplinary, incorporating perspectives in Exome sequencing, Breast cancer, Polycythemia vera and Proto-Oncogene Proteins B-raf.

His Breast cancer study integrates concerns from other disciplines, such as Penetrance, Hereditary breast–ovarian cancer syndrome and Gene mutation. The concepts of his Genome study are interwoven with issues in Gene rearrangement, Germline mutation and Somatic cell. P. Andrew Futreal interconnects Targeted therapy, Carcinoma, Melanoma, Lung cancer and Kinase in the investigation of issues within Mutation.

His most cited work include:

• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 (5177 citations)
• A census of human cancer genes (2604 citations)
• The cancer genome (2310 citations)

What are the main themes of his work throughout his whole career to date?

P. Andrew Futreal focuses on Genetics, Cancer research, Cancer, Mutation and Gene. His study in Human genome, Genome, Carcinogenesis, X chromosome and Exome sequencing is carried out as part of his Genetics studies. Many of his research projects under Human genome are closely connected to Nucleic acid amplification technique with Nucleic acid amplification technique, tying the diverse disciplines of science together.

His Cancer research research incorporates themes from Germline mutation, Malignancy, Carcinoma, Tumor suppressor gene and Breast cancer. His Cancer research integrates issues from COSMIC cancer database, Somatic cell, Oncology and Pathology. His research investigates the connection between Mutation and topics such as Lung cancer that intersect with problems in Kinase.

He most often published in these fields:

• Genetics (47.12%)
• Cancer research (31.73%)
• Cancer (27.88%)

What were the highlights of his more recent work (between 2013-2021)?

• Cancer research (31.73%)
• Cancer (27.88%)
• Pathology (7.69%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Cancer, Pathology, Adenoid cystic carcinoma and Carcinoma. His study in the field of Myeloid leukemia is also linked to topics like Atlas. As part of his studies on Cancer, P. Andrew Futreal often connects relevant subjects like Transcriptome.

His research in Pathology intersects with topics in Gene expression, Gene expression profiling, Tumor microenvironment, Concordance and MSH6. His study in Adenoid cystic carcinoma is interdisciplinary in nature, drawing from both Germline mutation, Malignancy, Head and neck cancer, Carcinogenesis and Intratumoral Genetic Heterogeneity. P. Andrew Futreal works mostly in the field of Carcinoma, limiting it down to topics relating to Metastasis and, in certain cases, Genetic heterogeneity.

Between 2013 and 2021, his most popular works were:

• Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing (842 citations)
• Recurrent PTPRB and PLCG1 mutations in angiosarcoma (172 citations)
• Genomic heterogeneity of multiple synchronous lung cancer (80 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Mutation
• DNA

The scientist’s investigation covers issues in Cancer research, Genetics, Mutation, PTEN and CDH1. His Cancer research research includes elements of Missense mutation and Angiosarcoma. Genetics is represented through his Exome sequencing, CpG site, Tumor progression, Clear cell and PBRM1 research.

He has included themes like Lung cancer, Human genetics and Cohort in his Mutation study. His PTEN studies intersect with other disciplines such as GATA3, Cell Cycle Gene, Genome, Oncogene and Transcriptome. Borrowing concepts from Cancer, P. Andrew Futreal weaves in ideas under CDH1.